Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
Science
Storm Newton

Three-drug therapy ‘doubles breast cancer survival time without progression’

A three-drug combination targeting aggressive advanced breast cancer could potentially double the amount of time patients live without the disease progressing, a trial has found (David Davies/PA) - (PA Wire)

A three-drug combination targeting aggressive advanced breast cancer could potentially double the amount of time patients live without the disease progressing, a trial has found.

Researchers hailed the “huge breakthrough” as potentially “transformative” for those with a common form of breast cancer.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.